Development of inflammatory arthritis and enthesitis in patients on dupilumab: a case series

Br J Dermatol. 2019 Nov;181(5):1068-1070. doi: 10.1111/bjd.18031. Epub 2019 Jul 18.

Authors

Z N Willsmore¹, R T Woolf¹, C Hughes², B Menon², B Kirkham², C H Smith¹, A E Pink¹

Affiliations

¹ St. John's Institute of Dermatology, Guy's and St. Thomas' Hospital NHS Trust, GLondon, U.K.
² Department of Rheumatology, Guy's and St. Thomas' Hospital NHS Trust, GLondon, U.K.

PMID: 31017658
DOI: 10.1111/bjd.18031

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Aged
Antibodies, Monoclonal, Humanized / adverse effects*
Arthritis / chemically induced
Arthritis / diagnosis
Arthritis / immunology*
Dermatitis, Atopic / drug therapy*
Dermatitis, Atopic / immunology
Enthesopathy / chemically induced
Enthesopathy / diagnosis
Enthesopathy / immunology*
Female
Humans
Male
Middle Aged

Substances

Antibodies, Monoclonal, Humanized
dupilumab